LV12624B - Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana - Google Patents

Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana

Info

Publication number
LV12624B
LV12624B LV000135A LV000135A LV12624B LV 12624 B LV12624 B LV 12624B LV 000135 A LV000135 A LV 000135A LV 000135 A LV000135 A LV 000135A LV 12624 B LV12624 B LV 12624B
Authority
LV
Latvia
Prior art keywords
thienylazolylalkosietanamines
legusana
drug
application
drug legusana
Prior art date
Application number
LV000135A
Other languages
English (en)
Other versions
LV12624A (lv
Inventor
Ramon Merce-Vidal
Blas Andaluz-Mataro
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of LV12624A publication Critical patent/LV12624A/lv
Publication of LV12624B publication Critical patent/LV12624B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
LV000135A 1998-04-15 2000-11-03 Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana LV12624B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009800793A ES2150353B1 (es) 1998-04-15 1998-04-15 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
PCT/ES1999/000098 WO1999052525A1 (es) 1998-04-15 1999-04-15 Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos

Publications (2)

Publication Number Publication Date
LV12624A LV12624A (lv) 2001-03-20
LV12624B true LV12624B (lv) 2001-09-20

Family

ID=8303465

Family Applications (1)

Application Number Title Priority Date Filing Date
LV000135A LV12624B (lv) 1998-04-15 2000-11-03 Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana

Country Status (31)

Country Link
US (3) US6410582B1 (lv)
EP (1) EP1072266B8 (lv)
JP (1) JP2002511412A (lv)
KR (1) KR100523366B1 (lv)
CN (1) CN1189170C (lv)
AR (1) AR016210A1 (lv)
AT (1) ATE302604T1 (lv)
AU (1) AU754705B2 (lv)
BG (1) BG64891B1 (lv)
BR (1) BR9910124A (lv)
CA (1) CA2328878A1 (lv)
CO (1) CO5011045A1 (lv)
CU (1) CU22960A3 (lv)
CZ (1) CZ298222B6 (lv)
EE (1) EE04739B1 (lv)
ES (1) ES2150353B1 (lv)
GE (1) GEP20032913B (lv)
HU (1) HUP0102585A3 (lv)
IS (1) IS5662A (lv)
LT (1) LT4830B (lv)
LV (1) LV12624B (lv)
NO (1) NO320313B1 (lv)
NZ (1) NZ507573A (lv)
PL (1) PL343512A1 (lv)
RO (1) RO121690B1 (lv)
RU (1) RU2213743C2 (lv)
SI (1) SI20473A (lv)
SK (1) SK285039B6 (lv)
TW (1) TW528756B (lv)
UA (1) UA58589C2 (lv)
WO (1) WO1999052525A1 (lv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.
US6432954B1 (en) * 2000-07-14 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
ES2174756B2 (es) * 2001-04-06 2003-11-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
ES2180449B1 (es) * 2001-07-06 2004-01-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
CL2004001034A1 (es) 2003-05-14 2005-03-28 Teijin Pharma Ltd Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1671968A1 (en) 2004-12-17 2006-06-21 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1828175A2 (en) * 2004-12-17 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1674465A1 (en) * 2004-12-27 2006-06-28 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
ES2303795B1 (es) * 2004-12-27 2009-06-12 Laboratorios Del Dr. Esteve, S.A. Procedimiento para obtener enantiomeros de tienilazolilalcoxietanaminas.
WO2006069767A1 (en) * 2004-12-27 2006-07-06 Laboratorios Del Dr. Esteve, S.A. Process for obtaining enantiomers of thienylazolylalcoxyethanamines
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US20070149590A1 (en) * 2005-08-05 2007-06-28 Garcia Francisco J L Controlled release dosage form of pirazole compounds
EP1820502A1 (en) 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
CN102432845B (zh) * 2011-08-22 2013-03-13 电子科技大学 聚3,4-双乙基羟基噻吩气敏材料及其制备方法
EP3233805B1 (en) * 2014-12-15 2019-02-06 Esteve Pharmaceuticals, S.A. Methyl-1h-pyrazole-alkylamine compounds having multimodal activity against pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
ES2150353B1 (es) 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.

Also Published As

Publication number Publication date
CA2328878A1 (en) 1999-10-21
NZ507573A (en) 2002-07-26
RU2213743C2 (ru) 2003-10-10
GEP20032913B (en) 2003-03-25
CN1303283A (zh) 2001-07-11
CO5011045A1 (es) 2001-02-28
SK15282000A3 (sk) 2001-12-03
RO121690B1 (ro) 2008-02-28
HUP0102585A2 (hu) 2001-12-28
EE04739B1 (et) 2006-12-15
EE200000596A (et) 2002-06-17
US20020188017A1 (en) 2002-12-12
IS5662A (is) 2000-10-13
EP1072266A1 (en) 2001-01-31
UA58589C2 (uk) 2003-08-15
SI20473A (sl) 2001-08-31
HUP0102585A3 (en) 2002-04-29
EP1072266B1 (en) 2005-08-24
JP2002511412A (ja) 2002-04-16
CU22960A3 (es) 2004-06-21
KR20010042739A (ko) 2001-05-25
LT2000097A (en) 2001-03-26
TW528756B (en) 2003-04-21
AU3148399A (en) 1999-11-01
US20040162324A1 (en) 2004-08-19
ES2150353A1 (es) 2000-11-16
CZ20003764A3 (en) 2001-05-16
BG104853A (en) 2001-04-30
NO20005146L (no) 2000-12-14
PL343512A1 (en) 2001-08-27
ATE302604T1 (de) 2005-09-15
CN1189170C (zh) 2005-02-16
BG64891B1 (bg) 2006-08-31
KR100523366B1 (ko) 2005-10-20
CZ298222B6 (cs) 2007-07-25
SK285039B6 (sk) 2006-05-04
BR9910124A (pt) 2001-01-09
LT4830B (lt) 2001-08-27
AR016210A1 (es) 2001-06-20
ES2150353B1 (es) 2001-07-01
LV12624A (lv) 2001-03-20
WO1999052525A1 (es) 1999-10-21
EP1072266B8 (en) 2006-10-18
NO20005146D0 (no) 2000-10-13
US7129361B2 (en) 2006-10-31
US6410582B1 (en) 2002-06-25
AU754705B2 (en) 2002-11-21
NO320313B1 (no) 2005-11-21

Similar Documents

Publication Publication Date Title
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
ID23874A (id) Obat
NO20005913L (no) Legemiddelsammensetning
FI971279A (fi) Lääkkeitä
ID24555A (id) Popok sekali pakai
ID27415A (id) Komposisi farmaseutik
NO20011085D0 (no) Tablett med umiddelbar frigivningsvirkning
ID29089A (id) Sediaan farmasi moksifloksasin
ID29262A (id) Komposisi farmasi
NO992692L (no) Nefadozon doseringsform
ID23083A (id) Popok sekali pakai
ID27201A (id) Komposisi farmasi
DK1017392T3 (da) Lægemiddel
ID27150A (id) Sediaan levotiroksin bahan farmasi
ID29294A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
EA199900672A1 (ru) Гомеопатическое лекарственное средство
ID26215A (id) Komposisi farmasi
ATE238786T1 (de) Anti-first-pass-effect-substanzen
EA199900673A1 (ru) Гомеопатическое лекарственное средство
PT1235809E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos
ID23531A (id) Komposisi farmasi
FI972010A0 (fi) Arrangemang i en borrningsanordning
SE9803771D0 (sv) Pharmaceutical composition and use
SE9703737D0 (sv) Pharmaceutical composition and use